Quick Takeaways
- MENORA MIVTACHIM HOLDINGS LTD. filed SCHEDULE 13G/A for UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN).
- Disclosed ownership: 5%.
- Date of event: 11 Mar 2025.
MENORA MIVTACHIM HOLDINGS LTD. - 11 Mar 2025 SCHEDULE 13G/A Report for UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN)
- Filing Manager
- MENORA MIVTACHIM HOLDINGS LTD.
- Reporting Manager
- Menora Mivtachim Holdings Ltd
- Symbol
- URGN
- Shares outstanding
- 46,152,926 shares
- Disclosed Ownership
- 2,303,031 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Mar 2025, 13:23:02 UTC
- Date of event
- 11 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"MENORA MIVTACHIM HOLDINGS LTD. disclosed 5% ownership in UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN) on 11 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Mar 2025, 13:23.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Menora Mivtachim Holdings Ltd | 5% | 2,303,031 | 0 | 2,303,031 | /s/ Ran Kalmi | Ran Kalmi, CFO |